Back to MW MARSHALL WACE, LLP

XGNXGN
7 quarters

Position history for MWMARSHALL WACE, LLP's holdings in EXAGEN INC

Yes. Marshall Wace holds 306,703 shares of XGN (Exagen), worth $1.4M, as of its Q2 2026 13F filing. It increased the position from 27,289 shares in Q1 2026. Marshall Wace has held XGN since Q3 2025, across 4 quarterly 13F filings.

Current Value

$1.4M

Current Shares

306,703

Total Value Change

+$1.4M

Total Shares Change

+290,655

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
306,703
+1023.9%
$1.4M0.0%$4.65
41
2026-Q1
Decreased
27,289
-88.8%
$81,8670.0%$3.43
0
2025-Q4
Increased
243,424
+888.2%
$1.5M0.0%$6.01
41
2025-Q3
New
24,632
-
$270,7060.0%$10.77
32
2025-Q2
Exited
0
-100.0%
$00.0%$7.00
0
2025-Q1
Increased
106,559
+564.0%
$382,5470.0%$3.84
38
2024-Q4
New
16,048
-
$65,7960.0%$4.28
29

Other major holders of XGN: WASATCH ADVISORS LP, RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used